BioCentury
ARTICLE | Clinical News

Irribow ramosetron hydrochloride regulatory update

September 10, 2012 7:00 AM UTC

Astellas submitted a regulatory application to Japan's Ministry of Health, Labor and Welfare (MHLW) for Irribow ramosetron hydrochloride orally disintegrating tablets to treat diarrhea-predominant irr...